Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.21.2
Subsequent Events (Details Narrative) - shares
Oct. 06, 2021
Nov. 03, 2021
Nov. 02, 2021
Sep. 30, 2021
Dec. 31, 2020
Subsequent Event [Line Items]          
Common Stock, Shares Authorized       30,000,000 30,000,000
Subsequent Event [Member]          
Subsequent Event [Line Items]          
Common Stock, Shares Authorized   50,000,000 30,000,000    
Subsequent Event [Member] | License Agreement [Member] | Elion Oncology, Inc [Member]          
Subsequent Event [Line Items]          
Shares issued in private placement, net of transaction costs, shares 100,000